Bertil Lindahl

Q: What Schools Are Affiliated With Bertil Lindahl

Bertil Lindahl is affiliated with the following schools: Uppsala University, University of Alberta, University of Gothenburg

Bertil Lindahl's AcademicInfluence.com Rankings

Bertil Lindahl

Computer Science

#6173

World Rank

#6508

Historical Rank

Computational Linguistics

#1012

World Rank

#1026

Historical Rank

Machine Learning

#1915

World Rank

#1941

Historical Rank

Artificial Intelligence

#2164

World Rank

#2201

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Bertil Lindahl Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bertil Lindahl's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Third universal definition of myocardial infarction. (2012) (4123)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. (2000) (1299)
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. (2005) (1207)
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. (2004) (1056)
Third universal definition of myocardial infarction. (2012) (921)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co (2003) (786)
Third universal definition of myocardial infarction. (2012) (751)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing co (2003) (731)
Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. (2004) (653)
N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy (2003) (627)
Recommendations for the use of cardiac troponin measurement in acute cardiac care. (2010) (619)
Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. (1997) (565)
The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) (2009) (533)
Management of grown up congenital heart disease. (2003) (498)
How to use high-sensitivity cardiac troponins in acute cardiac care (2012) (484)
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. (1996) (460)
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. (1997) (444)
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. (2004) (419)
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction (2003) (377)
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. (2002) (373)
How to use high-sensitivity cardiac troponins in acute cardiac care. (2013) (345)
Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. (1999) (339)
Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome (2007) (333)
Review of 103 Swedish Healthcare Quality Registries (2015) (311)
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. (2004) (305)
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. (2002) (294)
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease (2017) (290)
Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. (2016) (288)
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. (2012) (288)
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. (2002) (281)
Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non–ST-Elevation Acute Coronary Syndrome (2004) (280)
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014 (2017) (270)
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. (2003) (265)
Oxygen Therapy in Suspected Acute Myocardial Infarction (2017) (254)
Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. (2004) (220)
IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. (2015) (218)
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome (2007) (216)
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. (2009) (211)
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. (2007) (201)
Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value. (2012) (200)
Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study. (2016) (198)
Type 2 myocardial infarction in clinical practice (2014) (180)
Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. (2009) (171)
How is cardiac troponin released from injured myocardium? (2018) (170)
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. (2019) (169)
Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women (2000) (163)
Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). (2002) (162)
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction (2017) (162)
Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. (2008) (159)
Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. (2006) (149)
Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality (2007) (149)
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. (2002) (146)
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. (2003) (142)
Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. (2005) (141)
Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. (2010) (140)
ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease. The FRISC II ECG substudy (2002) (131)
Digoxin and mortality in atrial fibrillation: a prospective cohort study (2007) (125)
Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry (2017) (121)
Management of Grown Up Congenital Heart Disease The Task Force on the Management of Grown Up Congenital Heart Disease of the European Society of Cardiology (2003) (121)
Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. (2013) (118)
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. (2006) (117)
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. (1997) (116)
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease (2005) (112)
The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. (2010) (111)
GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men (2013) (109)
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. (2004) (100)
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial (2019) (99)
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II). (1999) (99)
Biochemical indicators of cardiac and renal function in a healthy elderly population. (2004) (98)
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis. (2015) (98)
A 1-h Combination Algorithm Allows Fast Rule-Out and Rule-In of Major Adverse Cardiac Events. (2016) (97)
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome (2007) (96)
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. (2003) (95)
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014 (2018) (93)
Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. (2009) (92)
Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. (2013) (91)
Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study. (2016) (90)
Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. (2009) (87)
Symptoms and type of symptom onset in acute coronary syndrome in relation to ST elevation, sex, age, and a history of diabetes. (2005) (86)
Cardiac troponin: a critical review of the case for point-of-care testing in the ED. (2012) (86)
Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome (2010) (84)
Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery (MINOCA) disease. (2018) (82)
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction (2002) (81)
Possible mechanisms behind cardiac troponin elevations (2018) (81)
ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease. (2002) (80)
Thoughts, actions, and factors associated with prehospital delay in patients with acute coronary syndrome. (2007) (80)
Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. (2002) (79)
The antibody configurations of cardiac troponin I assays may determine their clinical performance. (2006) (78)
[Fourth universal definition of myocardial infarction (2018)]. (2018) (78)
Guidelines for the Management of Patients With Supraventricular Arrhythmias * — Executive Summary (2003) (78)
N-Terminal Pro-Brain Natriuretic Peptide in Relation to Inflammation, Myocardial Necrosis, and the Effect of an Invasive Strategy in Unstable Coronary Artery Disease (2004) (78)
Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome. (2017) (78)
Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries (2013) (77)
ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. (1999) (77)
Natriuretic peptides in unstable coronary artery disease. (2004) (75)
Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. (2013) (75)
Clinical performance of two highly sensitive cardiac troponin I assays. (2009) (75)
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. (2003) (74)
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. (1998) (74)
Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART Registry. (2015) (71)
Rapid rule out of acute myocardial infarction: novel biomarker-based strategies (2017) (71)
Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. (2010) (71)
How to use D-dimer in acute cardiovascular care (2017) (70)
Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study. (2006) (70)
What to do when you question cardiac troponin values (2018) (70)
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip (2015) (69)
Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction (2018) (69)
Impact on Long-Term Mortality of Presence of Obstructive Coronary Artery Disease and Classification of Myocardial Infarction. (2016) (68)
The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test. (2016) (67)
Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain (2008) (67)
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. (2003) (66)
Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. (2004) (66)
Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? (2009) (66)
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction (2013) (65)
Consequences of implementing a cardiac troponin assay with improved sensitivity at Swedish coronary care units: an analysis from the SWEDEHEART registry. (2016) (65)
Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department (1997) (65)
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study (2016) (65)
DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. (2014) (62)
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis. (2019) (62)
NT‐proBNP in unstable coronary artery disease—experiences from the FAST, GUSTO IV and FRISC II trials (2004) (62)
Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease (1997) (62)
Factors that influence the use of ambulance in acute coronary syndrome. (2008) (61)
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. (2003) (59)
Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis. (1997) (58)
High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain. (2012) (58)
Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department (2017) (58)
Prognostic value of ST-segment resolution-when and what to measure. (2003) (58)
The combination of a continuous 12-lead ECG and troponin T; a valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG. (2000) (57)
Soluble CD40L Levels Are Regulated by the −3459 A>G Polymorphism and Predict Myocardial Infarction and the Efficacy of Antithrombotic Treatment in Non-ST Elevation Acute Coronary Syndrome (2006) (56)
Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes. (1995) (56)
Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patients. (2007) (56)
Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial. (2004) (55)
Time trends and gender differences in prevention guideline adherence and outcome after myocardial infarction: Data from the SWEDEHEART registry (2016) (54)
High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. (2013) (53)
Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology (2011) (53)
Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. (2000) (52)
Revision of the troponin T release mechanism from damaged human myocardium. (2014) (52)
The applied statistical approach highly influences the 99th percentile of cardiac troponin I. (2016) (52)
Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. (2010) (51)
Myeloperoxidase is not useful for the early assessment of patients with chest pain. (2010) (51)
Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. (2013) (51)
β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study (2015) (51)
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome (2020) (50)
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. (2004) (50)
Association between obstructive sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women. (2012) (50)
How to use C-reactive protein in acute coronary care. (2013) (50)
Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction. (2011) (49)
Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction (2014) (49)
Fetal exposure, heredity and risk indicators for cardiovascular disease in a Swedish welfare cohort. (2001) (48)
Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction (2005) (48)
Long-Term Outcome of Incomplete Revascularization After Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry). (2016) (48)
Early diagnosis of acute coronary syndrome (2017) (47)
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study (2020) (47)
NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach. (2016) (47)
The low‐molecular‐weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS study (2001) (46)
Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. (2014) (46)
Patients' and Relatives' Thoughts and Actions During and after Symptom Presentation for an Acute Myocardial Infarction (2007) (46)
Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study (2015) (45)
The story of growth differentiation factor 15: another piece of the puzzle. (2013) (45)
New generation cardiac troponin I assay for the access immunoassay system. (2001) (45)
Use of copeptin for rapid rule-out of acute myocardial infarction (2018) (44)
Why all the struggle about CK-MB and PCI? (2012) (44)
Factors of importance for patients' decision time in acute coronary syndrome. (2010) (44)
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). (2006) (43)
Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013 (2018) (43)
Impact of Sex on Cardiac Troponin Concentrations-A Critical Appraisal. (2017) (42)
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. (2015) (41)
In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association (2014) (40)
Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis. (2019) (40)
Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department (2017) (40)
Type 2 myocardial infarction: the chimaera of cardiology? (2015) (40)
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic (2020) (39)
Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review. (2018) (39)
Improved Clinical Outcome After Acute Myocardial Infarction in Hospitals Participating in a Swedish Quality Improvement Initiative (2009) (38)
Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. (2012) (38)
Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group. (1997) (37)
Unstable Angina in the Era of Cardiac Troponin Assays with Improved Sensitivity-A Clinical Dilemma. (2017) (37)
Interphysician agreement on subclassification of myocardial infarction (2018) (37)
Is patient involvement during hospitalization for acute myocardial infarction associated with post‐discharge treatment outcome? An exploratory study (2010) (36)
Knowledge and attitudes toward seeking medical care for AMI-symptoms. (2011) (35)
Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. (2017) (35)
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design. (2020) (35)
Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin (2017) (34)
Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? (2017) (34)
Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS). (2011) (33)
Improving Guideline Adherence Through Intensive Quality Improvement and the Use of a National Quality Register in Sweden for Acute Myocardial Infarction (2007) (33)
Cardiac Biomarkers (2015) (33)
Platelet function testing in acute cardiac care – is there a role for prediction or prevention of stent thrombosis and bleeding? (2014) (33)
Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction. (2012) (33)
The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers. (1998) (32)
Morbidity and cause‐specific mortality in first‐time myocardial infarction with nonobstructive coronary arteries (2018) (32)
Cardiovascular biomarkers in patients with COVID-19 (2021) (32)
Statistics on mortality following acute myocardial infarction in 842,897 Europeans. (2019) (31)
Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction. (2004) (30)
Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease (2004) (30)
The Liver and Kidneys mediate clearance of cardiac troponin in the rat (2020) (29)
Cardiac troponin I levels in an elderly population from the community--The implications of sex. (2015) (29)
Diagnostic Accuracy of High-Sensitivity Cardiac Troponin T at Presentation Combined With History and ECG for Ruling Out Major Adverse Cardiac Events. (2016) (29)
Prognostic Importance of Sex-Specific Cardiac Troponin T 99(th) Percentiles in Suspected Acute Coronary Syndrome. (2016) (28)
A Rule‐Out Strategy Based on High‐Sensitivity Troponin and HEART Score Reduces Hospital Admissions (2019) (28)
Prognosis in relation to high‐sensitivity cardiac troponin T levels in patients with myocardial infarction and non‐obstructive coronary arteries (2018) (28)
Oxygen therapy in ST-elevation myocardial infarction (2018) (28)
Risk stratification in unstable coronary artery disease--exercise test and troponin T from a gender perspective. FRISC-Study Group. Fragmin during InStability in Coronary artery disease. (1997) (28)
Diagnosis of acute myocardial infarction in the presence of left bundle branch block (2019) (28)
Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring (1995) (27)
Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction. (2002) (26)
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden (2012) (25)
Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction. (2013) (25)
An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay (2016) (25)
Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally? (2016) (24)
Possible reasons for the prognostic value of troponin‐T on admission in patients with ST‐elevation myocardial infarction (2001) (24)
A 0‐Hour/1‐Hour Protocol for Safe, Early Discharge of Chest Pain Patients (2017) (24)
High-Sensitivity Cardiac Troponin-Based Strategies for the Assessment of Chest Pain Patients-A Review of Validation and Clinical Implementation Studies. (2018) (22)
Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction. (2019) (22)
Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk? (2014) (22)
A Possible Mechanism behind Faster Clearance and Higher Peak Concentrations of Cardiac Troponin I Compared with Troponin T in Acute Myocardial Infarction. (2020) (22)
A combination of troponin T and 12-lead electrocardiography: a valuable tool for early prediction of long-term mortality in patients with chest pain without ST-segment elevation. (2002) (22)
Autoantibodies to cardiac troponin in acute coronary syndromes. (2010) (21)
Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community. (2013) (21)
Achievement of Secondary Preventive Goals After Acute Myocardial Infarction: A Comparison Between Participants and Nonparticipants in a Routine Patient Education Program in Sweden (2009) (21)
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. (2008) (21)
B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years. (2009) (21)
Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins (2017) (20)
Increased risk of heart failure in women with symptoms of sleep-disordered breathing. (2016) (19)
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment. (2002) (19)
Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction (2018) (19)
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time (2017) (18)
Inequity of access to ACE inhibitors in Swedish heart failure patients: a register-based study (2015) (17)
Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis (2018) (17)
Short- and long-term individual variation in NT-proBNP levels in patients with stable coronary artery disease. (2013) (17)
Elevation of cardiac troponins measured after recreational resistance training. (2015) (17)
Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART. (2016) (16)
Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen Saturation. (2019) (16)
Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community. (2016) (16)
Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician (2015) (16)
Risk prediction in chest pain patients by biochemical markers including estimates of renal function. (2008) (16)
Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays (2013) (16)
ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMB. (2021) (16)
Effects on QRS-waveforms and ST-T-segment by changes in body position during continuous 12-lead ECG: a preliminary report (1997) (16)
The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients (2017) (16)
Quality Improvement in Coronary Care: Analysis of Sustainability and Impact on Adjacent Clinical Measures After a Swedish Controlled, Multicenter Quality Improvement Collaborative (2012) (15)
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration. (2021) (15)
From European to National guidelines on heart disease (2011) (14)
Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA) (2019) (14)
Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile. (2015) (14)
The composition and daily variation of microparticles in whole blood in stable coronary artery disease (2016) (14)
Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy. (2005) (13)
Cardiac Troponins and Their Prognostic Importance in Patients with Suspected Acute Coronary Syndrome and Renal Dysfunction. (2017) (13)
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries. (2019) (13)
Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives. (2013) (13)
Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging – Prognostic Implications (2016) (13)
Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project protocol and design (2010) (13)
Antiphospholipid Antibodies in Patients With Myocardial Infarction (2018) (12)
High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study (2017) (12)
Acute coronary syndrome – the present and future role of biomarkers1) (2013) (12)
Serum lipoprotein lipid and apolipoprotein concentrations in grossly obese patients before and after jejuno‐ileal shunt operation (1981) (12)
Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome (2018) (12)
Combining different biochemical markers of myocardial ischemia does not improve risk stratification in chest pain patients compared to troponin I alone (2005) (11)
Detection of Myocardial Damage – are the Troponins the Ultimate Solution? (2001) (11)
Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery (2015) (11)
Unrecognized myocardial infarction assessed by cardiac magnetic resonance imaging is associated with adverse long-term prognosis (2018) (11)
Comparison between Second and Third Generation Troponin T Assay in Patients with Symptoms Suggestive of an Acute Coronary Syndrome but without ST Segment Elevation (2003) (11)
High-Sensitivity Cardiac Troponin T Levels Identify Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Who Benefit From Invasive Assessment. (2018) (10)
Correction: Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department (2017) (10)
A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-score. (2017) (10)
Neural network analysis of biochemical markers for early assessment of acute myocardial infarction. (1997) (10)
Target-attainment rates of low-density lipoprotein cholesterol using lipid-lowering drugs one year after acute myocardial infarction in sweden. (2014) (10)
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention (2021) (10)
The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial (2021) (10)
Myocardial Infarction with Nonobstructive Coronary Arteries: The Importance of Achieving Secondary Prevention Targets. (2017) (10)
Relationship of plasma erythropoietin to long-term outcome in acute coronary syndrome. (2010) (10)
Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference (2014) (10)
Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population. (2015) (10)
Principal Component Analysis of the T Wave in Patients with Chest Pain and Conduction Disturbances (2004) (10)
Cardiac troponin I associated with the development of unrecognized myocardial infarctions detected with MRI. (2014) (10)
Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry (2021) (10)
Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study (2016) (9)
Pregnancy Complications and Risk of Cardiovascular Disease Later in Life: A Nationwide Cohort Study (2022) (9)
Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly. (2018) (9)
ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy. (2004) (9)
NT-ProBNP in non-ST-elevation acute coronary syndrome. (2005) (9)
Comparison of continuous vectorcardiography and continuous 12‐lead electrocardiography of patients with unstable coronary artery disease: do they identify the same population? (2001) (9)
Decreased admissions and hospital costs with a neutral effect on mortality following lowering of the troponin T cutoff point to the 99th percentile. (2017) (9)
Biochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: Experiences from the Nordic countries (2005) (9)
Sensitive troponin I assay in patients with suspected acute coronary syndrome. (2011) (9)
Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples. (2017) (9)
Risk prediction in patients with chest pain: early assessment by the combination of troponin I results and electrocardiographic findings (2005) (9)
Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction. (2018) (8)
Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm (2021) (8)
Dynamic vectorcardiography for early diagnosis of acute myocardial infarction compared with 12‐lead electrocardiogram (1996) (8)
Are there really biomarkers of vulnerable plaque? (2012) (8)
Unrecognized myocardial scars detected by delayed–enhanced MRI are associated with increased levels of NT-proBNP (2011) (8)
Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease. (1999) (8)
Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease. (2003) (7)
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry). (2021) (7)
Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study. (2022) (7)
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction. (2021) (7)
Biochemical markers of myocardial damage for early diagnosis and prognosis in patients with acute coronary syndromes. Minireview based on a doctorial thesis. (1996) (7)
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study (2020) (7)
Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry (2020) (7)
Continuous multilead ST-segment monitoring should be a part of the clinical routine. (2002) (7)
Multimarker approach for diagnosis of acute myocardial infarction: better answers need better questions. (2009) (7)
Early Diagnosis and Exclusion of Acute Myocardial Infarction by Two Hours' Vector-ECG and Determination of Either Myoglobin or CK-mb (2000) (7)
Sex differences in investigations and outcomes among patients with type 2 myocardial infarction (2021) (7)
Prognostic Value of Ischemia Monitoring with On-Line Vectorcardiography in Patients with Unstable Coronary Artery Disease (2000) (7)
Sensitivity of undetectable level of high-sensitivity troponin T at presentation in a large non-ST-segment elevation myocardial infarction cohort of early presenters. (2019) (7)
Markers of myocardial damage in acute coronary syndromes--therapeutic implications. (2001) (7)
[Care of myocardial infarction strongly improved 1995-2005. Quality registry, open statements and clear therapeutic goals have payed off]. (2007) (6)
The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients (2022) (6)
Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography (2005) (6)
Diagnosing type 2 myocardial infarction in clinical routine. A validation study (2019) (6)
Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain (2018) (6)
Therapeutic implications of the use of cardiac markers in acute coronary syndromes. (1999) (6)
Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design (2019) (6)
Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI. (2005) (6)
Sometimes earlier may not be better (2016) (6)
Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis. (2020) (6)
Early rule out of acute myocardial infarction (2017) (6)
Influence of health-related quality of life on time from symptom onset to hospital arrival and the risk of readmission in patients with myocardial infarction (2014) (6)
Sex differences in sickness absence and the morbidity-mortality paradox: a longitudinal study using Swedish administrative registers (2019) (5)
Non‐dipolar content of the T‐wave as a measure of repolarization inhomogeneity in ST‐elevation myocardial infarction (2006) (5)
Prognostic implications of changes in cardiac troponin I levels in patients with non-ST elevation acute coronary syndrome (2013) (5)
Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction. (2002) (5)
Soluble CD 40 L Levels Are Regulated by the 3459 A > G Polymorphism and Predict Myocardial Infarction and the Efficacy of Antithrombotic Treatment in Non-ST Elevation Acute Coronary Syndrome (2006) (5)
Cardiac troponin I, NT-proBNP and galactin-3 are elevated in patients with unrecognized myocardial infarction detected by cardiac magnetic resonance imaging (2014) (5)
Unrecognized myocardial infarctions detected by cardiac magnetic resonance imaging are associated with cardiac troponin I levels. (2016) (5)
Knowledge about Acute Myocardial Infarction (AMI) and attitudes to medical care seeking : a comparison between patients and the general public (2012) (5)
Early diagnosis and exclusion of acute myocardial infarction by two hours' vector-ECG and determination of either myoglobin or CK-mb. BIOMACS-study. BIOchemical Markers in Acute Coronary Syndromes. (2000) (4)
QT dispersion measured by an automatic continuous method early in patients admitted for chest pain. (2002) (4)
Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study. (2020) (4)
Treatment and Prognosis of Myocardial Infarction Outside Cardiology Departments (2020) (4)
Strong development of research based on national quality registries in Sweden (2018) (4)
High‐sensitivity cardiac troponin T, left ventricular function, and outcome in non–ST elevation acute coronary syndrome (2018) (4)
Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study (2020) (4)
Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers. (2021) (4)
The role of quality registries in health care improvement (2016) (4)
The Relation of QT Dispersion and Localized QT Difference to Coronary Pathology in a Population with Unstable Coronary Artery Disease (2003) (4)
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial (2020) (4)
Biobank linked to SWEDEHEART quality registry—routine blood sample collection opens new opportunities for cardiovascular research (2018) (4)
Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention (2021) (4)
Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial (2019) (4)
Experiences of a One-hour Algorithm in Chest Pain Patients With a Nonelevated Troponin T at Presentation (2018) (4)
Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction (2020) (4)
Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction—Insights From the Randomized DETO2X-AMI Trial (2021) (4)
Response by Lindahl et al to Letter Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease". (2017) (3)
Coronary angiography in relation to troponin T level in patients with unstable coronary artery disease (UCAD) - a FRISC-2 substudy (2000) (3)
Novel clearance of muscle proteins by muscle cells. (2020) (3)
Clinical and prognostic implications of high-sensitivity cardiac troponin T concentrations in type 2 non-ST elevation myocardial infarction (2022) (3)
Poor long‐term prognosis in patients admitted with strong suspicion of acute myocardial infarction but discharged with another diagnosis (2021) (3)
Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries (2021) (3)
Ischaemia monitoring with on‐line vectorcardiography during dobutamine stress echocardiography in patients after an episode of unstable coronary artery disease (1998) (3)
[Swedish work with national guidelines can become an international model. With perspectives from cardiovascular diseases guidelines]. (2008) (3)
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry. (2022) (3)
Observer Variability and Optimal Criteria of Transient Ischemia During ST Monitoring with Continuous 12‐lead ECG (2002) (3)
Diagnosis and Management of Patients with Suspected Acute Myocardial Infarction (2005) (3)
No beneficial effect of 24-48 hours abciximab infusion in aspirin and heparin treated acute coronary syndrome patients with elevated troponin without early revascularisation procedures A GUSTO-IV ACS Substudy (2001) (3)
Uppsala Clinical Research Center—development of a platform to promote national and international clinical science (2018) (3)
Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death. (2021) (3)
Analytic Performance of a Point-of-Care Instrument for Measurement of Cardiac Markers : An Evaluation Under Clinical Conditions (2003) (3)
Acute Coronary Syndrome Prognostic Value of Biomarkers During and After NonST-Segment Elevation (2011) (2)
Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain (2022) (2)
Risk Stratification of Chest Pain N-Terminal Pro Brain Natriuretic Peptide on Admission for Early Risk Stratification of Patients With Chest Pain and No ST-Segment Elevation (2002) (2)
Development of myocardial microcirculation and metabolism in acute ST- elevation myocardial infarction evaluated with PET (2005) (2)
[Uniform diagnosis of myocardial infarction. Rapid development at Swedish hospitals]. (1998) (2)
Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease (2019) (2)
Unstable coronary artery disease (2009) (2)
[Elevated troponin level and acute heart failure in epileptic attack]. (2010) (2)
Randomized Evaluation of Beta Blocker and ACE-Inhibitor/Angiotensin Receptor Blocker Treatment for Post Infarct Angina in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries: A MINOCA-BAT Sub Study Rationale and Design (2021) (2)
Effectiveness and Safety of the European Society of Cardiology 0-/1-h Troponin Rule-Out Protocol: The Design of the ESC-TROP Multicenter Implementation Study (2020) (2)
Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes. (2017) (2)
Cardiac Troponin for Risk Assessment and Management of Non-ST-Elevation Acute Coronary Syndrome (2006) (2)
A comparison of echocardiographic and circulating cardiac biomarkers for predicting incident cardiovascular disease (2022) (2)
More is worse--ST-segment deviation in unstable coronary artery disease. (1999) (2)
Determination of the role of Oxygen in Acute Myocardial Infarction(DETO2X-AMI trial) (2013) (2)
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex related outcomes from DETO2X-AMI. (2021) (2)
Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome (2022) (1)
2272A rapid rule-out strategy based on high sensitive troponin and HEART score implemented in clinical routine is safe and reduces admission to hospital (2017) (1)
Fibrinogen and C-reactive protein are prognostic factors for short-term outcome in unstable coronary artery disease (1997) (1)
Impact Of Markedly Elevated Initial High -Sensitivity Cardiac Troponin T On Prediction Of Acute Myocardial Infarction In Chest Pain Patients And Additional Value Of Kinetic Changes : Results From The Trapid-AMI Study (2015) (1)
High event rate in patients with acute coronary syndromes and atrial fibrillation: Results from the prospective EPICOR Registry (2015) (1)
PROGNOSTIC SIGNIFICANCE OF AN ELEVATED CONVENTIONAL OR HIGH-SENSITIVITY CARDIAC TROPONIN IN PATIENTS WITH CHEST PAIN WITH AND WITHOUT A DIAGNOSIS OF MYOCARDIAL INFARCTION (2015) (1)
Abstract 2060: Persisting Troponin I Elevations Predict Adverse Outcome in Stabilized Patients After an Episode of Acute Coronary Syndrome. (2006) (1)
Prognostic Utility of a Modified HEART Score When Different Troponin Cut Points Are Used (2021) (1)
PROGNOSTIC UTILITY OF A MODIFIED HEART SCORE WHEN DIFFERENT TROPONIN CUT-POINTS ARE USED (2019) (1)
P1739Combining the European Society of Cardiology troponin algorithms and HEART Score for ruling out acute coronary syndrome in unselected patients presenting with acute chest pain: The WESTCOR study (2018) (1)
Book Review Markers in Cardiology: Current and Future Clinical Applications (American Heart Association Monograph Series.) Edited by Jesse E. Adams III, with Fred S. Apple, Allan S. Jaffe, and Alan H.B. Wu. 272 pp. Armonk, N.Y., Futura, 2001. $79. 0-87993-472-7 (2001) (1)
Acute Myocardial Infarction Low Molecular Weight Heparin ( Dalteparin ) as Adjuvant Treatment to Thrombolysis in Acute Myocardial Infarction — A Pilot Study : Biochemical Markers in Acute Coronary Syndromes ( BIOMACS II ) (2016) (1)
CLINICAL EFFECTS OF INTRODUCING HIGH SENSITIVE CARDIAC TROPONIN T INTO CLINICAL PRACTICE: DATA FROM 48,594 PATIENTS IN THE SWEDEHEART REGISTRY (2014) (1)
Quantification of peri-operative myocardial infarction after coronary artery bypass surgery (2004) (1)
The protective effects of long-term lmw heparin (dalteparin) treatment in unstable CAD is confined to patients not previously treated with statins (2000) (1)
[Riks-HIA will develop a new index for areas with room for improvement]. (2012) (1)
[BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation]. (2006) (1)
Antithrombotic treatment in patients with unstable coronary artery disease undergoing CABG. (2001) (1)
[Biobank linked to Swedeheart, a resource for future research]. (2013) (1)
P4570Pre- and postoperative atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome (2017) (1)
Survival after Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) – A Comprehensive Systematic Review and Meta-Analysis from MINOCA Global Collaboration (2020) (1)
Application of the fourth universal definition of myocardial infarction in clinical practice (2020) (1)
884-2 Cardiac dysfunction in non-ST elevation ACS is partly reversible: Analysis of serial measurements of NT-Pro B-type natriutetic peptide (2004) (1)
Improving the management of non-ST elevation acute coronary syndromes : systematic evaluation of a quality improvement programme E uropean (2010) (1)
Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer: An Application to Coronary Thrombus Aspiration (2022) (1)
Acute coronary syndromes : from treatment to prevention . The enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory (2006) (1)
Reinfarction in patients with previous myocardial infarction with non-obstructive coronary arteries (MINOCA), findings at coronary angiography (2018) (1)
Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implications (2022) (1)
The inter-relationship between creatinine clearance, cardiac troponin T and outcomes in patients with acute coronary syndromes (2002) (1)
Troponin T Identiﬁes Patients With Unstable Coronary Artery Disease Who Beneﬁt From Long-Term Antithrombotic Protection (2016) (1)
88Oxygen therapy in myocardial infarction patients with or without diabetes mellitus - A predefined subgroup analysis from the DETO2X-AMI trial (2019) (1)
Non-employment and low educational level as risk factors for inequitable treatment and mortality in heart failure: a population-based cohort study of register data (2021) (1)
Combination of continuous 12-lead ECG and troponin T: a valuable prognostic tool for early risk stratification in patients with chest pain and a non-diagnostic ECG. (2000) (1)
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function. (2022) (1)
[A rapid troponin T test in acute chest pain. Evaluation in the routine clinical work]. (1995) (1)
GRACE 2.0 Score for Risk Prediction in Myocardial Infarction With Nonobstructive Coronary Arteries (2021) (1)
2209Oxygen therapy in suspected acute myocardial infarction and concurrent chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial (2019) (1)
Acute coronary syndromes Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments : experiences from the SWEDEHEARTregistry 1995 – 2014 (2017) (0)
Chapter 12 Databases, registries, and quality of care (2010) (0)
IgG Antiphospholipid Antibodies, -a Common but Neglected Finding in Patients with Myocardial Infarction (2018) (0)
Background characteristics and prognosis in non-invasively treated patients with type 1 and type 2 myocardial infarction. Data from the SWEDEHEART registry (2015) (0)
Symptoms and Type of Symptom Onset in Acute Coronary Syndrome in Relation to ST Elevation, Sex, Age, and a History of Diabetes (2005) (0)
Differences in biomarker concentrations and prediction of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction (2021) (0)
P2717Can biomarkers help to understand the pathology in myocardial infarction with normal coronary arteries (2017) (0)
Reliability of estimating left ventricular ejection fraction in clinical routine: a validation study of the SWEDEHEART registry (2022) (0)
Early risk stratification in ST-elevation myocardial infarction with admission Troponin T and ST-segment resolution (2002) (0)
[2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone]. (2008) (0)
P3666A simplified HEART-score improves discrimination for myocardial infarction in chest pain patients presenting to the emergency department (2018) (0)
P2708Distinguishing myocardial infarction type 2: how hard can it be? (2017) (0)
Personalized diagnosis in suspected myocardial infarction. (2023) (0)
Reply: The Validity of "Without a Specific Diagnosis" in Patients With Chest Pain and Troponin Elevation. (2019) (0)
Does sleep disordered breathing in women promote heart failure? : A population based cohort study (2014) (0)
Abstract 2068: Growth-Differentiation Factor-15 is a New Biomarker that Provides Prognostic Information Beyond Established Biomarkers in Patients with Non-ST-Elevation Acute Coronary Syndrome (2006) (0)
Myocardial infarction survival in patients with bipolar disorder or schizophrenia spectrum disorders- a nationwide cohort study (2014) (0)
Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006–2017 (2020) (0)
5130Association between degree of LDL-cholesterol decrease after a myocardial infarction and mortality - a nationwide cohort study (2019) (0)
Gaps in Our Biomarker Armamentarium: What Novel Biomarkers Might Be Synergistic in Patients with Acute Disease (2016) (0)
Biochemical biomarkers associated with peripheral artery disease contribute to prediction of outcome during long-term follow up after myocardial infarction (2019) (0)
Domain specific anti-beta 2GPI antibodies in patients with First Myocardial Infarction (2019) (0)
P4678Impact of the U.S. FDA regulatory approach not to report high-sensitivity cardiac troponin T concentrations below 6 ng/l on the ESC 0/1-hour algorithm for rule-out/in of acute myocardial infarction (2017) (0)
Coronary heart disease Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction (2007) (0)
Abstract 1193: Unrecognized Myocardial Scars Detected by Delayed-enhanced Magnetic Resonance Imaging are Associated with Increased Levels Of N-terminal Pro-brain Natriuretic Peptide (2008) (0)
Gender inequity in heart failure treatment affects mortality in a Swedish total population cohort (2016) (0)
P5585Diagnosis of acute myocardial infarction in patients presenting with left bundle branch block (2017) (0)
Predictors of in-hospital ventricular arrhythmias in patients admitted with suspected non-ST-elevation acute coronary syndrome : data from the SWEDEHEART registry (2014) (0)
Diagnostic applications of natriuretic peptides in ischemic heart disease. (2006) (0)
The Liver and Kidneys mediate clearance of cardiac troponin in the rat (2020) (0)
Guidelines on the diagnosis and treatment of acute heart failure — full (2005) (0)
Differences in background characteristics between patients with type 1 and type 2 myocardial infarction. Data from the SWEDEHEART registry (2013) (0)
Experiences of a one-hour troponin algorithm at the emergency department - dynamic changes are uncommon at initial low levels but relate to rate of admission and myocardial infarction among admitted (2016) (0)
P Biomarkers and Coronary Disease roponin-T and N-Terminal ProB-Type atriuretic Peptide Predict Mortality Benefit From oronary Revascularization in Acute Coronary Syndromes (2006) (0)
P860Adding clinical risk scores to troponin-based rule-out algorithms improves identification of patients at high risk for coronary revascularization within 6 weeks: the WESTCOR study (2019) (0)
Derivation and validation of a novel 3-hour pathway for the observe-zone of the ESC 0/1h-algorithm (2021) (0)
P2124High sensitivity troponin T is a stronger predictor than early infarct size determined by CMR for long-term ejection fraction (2017) (0)
Can biomarkers help to understand the pathology in myocardial infarction with normal coronary arteries? HEART, TIMI and GRACE scores (0)
Disease Markers Cardiac Biomarkers (2015) (0)
Management and outcome trends in type 2 myocardial infarction: an investigation from the SWEDEHEART registry (2023) (0)
Accuracy of estimating left ventricular ejection fraction in clinical routine. A SWEDEHEART registry validation study (2021) (0)
An important risk indicator in unstable coronary artery disease. (1996) (0)
Background characteristics, treatment and long-term prognosis in patients with significant coronary artery stenosis classified as type 1 or type 2 myocardial infarction. Data from SWEDEHEART registry (2015) (0)
[Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice]. (2004) (0)
Differences between cardiac Troponin I versus T according to the duration of myocardial ischemia. (2023) (0)
Prehospital diagnosis and start of treatment reduce time delay and mortality in real life patients with ST-elevation myocardial infarction (2005) (0)
Abstract 15603: Does Repeat Measurement of High Sensitivity Troponin I Improve Prediction of Cardiovascular Events in Atrial Fibrillation? (2014) (0)
Unrecognized myocardial infarction assessed by CMR is associated with hemodynamically significant stenosis at coronary angiography in patients with stable angina pectoris (2013) (0)
Response to letter regarding article, "Discontinuation of smokeless tobacco and mortality risk after myocardial infarction". (2015) (0)
TCT-462 Invasive Strategies And Outcomes For Non-ST-segment Elevation Acute Coronary Syndromes: A Twelve-year Experience From SWEDEHEART (2012) (0)
[No evidence of the benefit of new policy in asymptomatic pre-excitation]. (2009) (0)
Type 1 or type 2 myocardial infarction in patients without significant coronary artery disease - do we choose clinical type by chance? : Data from the SWEDEHEART registry (2015) (0)
Lipid-related Genes and Their Associations with Coronary Heart Disease (2014) (0)
Care of myocardial infarction: Sweden excels (2015) (0)
P1358Myocardial infarction with non-obstructive coronary arteries is not a benign disorder: results from the SWEDEHEART registry (2017) (0)
The Reply. (2017) (0)
Real-life use, and effects on lipid levels, of lipid lowering treatments after acute myocardial infarction in Sweden (2010) (0)
High-Sensitivity Cardiac Troponin T, Age, and Outcome in Non-ST-Elevation Myocardial Infarction. (2021) (0)
Risk-associated management disparities in acute myocardial infarction (2021) (0)
Abstract 152: A Novel Targeted Proteomics Approach Discovers Biomarkers for Human Atherosclerosis (2015) (0)
Abstract 19292: Growth-differentiation Factor-15 Contributes to Evaluation of Cardiovascular Risk in Healthy Elderly Men in Addition to Cardiovascular History, Risk Factors and Other Biomarkers (2010) (0)
[Erroneous view on the humanities in medical education]. (1989) (0)
How do we treat patients with type 2 (secondary) myocardial infarction in clinical practice? Data from the SWEDEHEART registry (2013) (0)
The effect of digoxin on mortality – a cohort study of patients with atrial fibrillation, heart failure or both (2005) (0)
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study (2020) (0)
Outcome of myocardial infarction in the unselected population is vastly different from samples of eligible patients in large-scale clinical trials (2002) (0)
[Biochemical markers enable early diagnosis of myocardial damage]. (1998) (0)
Abstract 15468: Age- and Gender-specific 99th Percentile Cut-offs for Diagnosis of Myocardial Infarction and Prognostic Implications - Results From the High Sensitivity Cardiac Troponin T Assay for Rapid Rule-out of Acute Myocardial Infarction Substudy (2014) (0)
Utility of echocardiography in patients with suspected acute myocardial infarction in the presence of left bundle-branch block (2020) (0)
[Assessment of troponin levels on the emergency ward]. (2017) (0)
Spironolactone use is associated with lower risk of prostate cancer (2020) (0)
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome (2022) (0)
Heart failure mortality in relation to unequal access to Renin-Angiotensin system blocking therapy. : A register based study. (2016) (0)
P4693Myocardial infarction outside the cardiology department: who are the patients we disqualify? (2017) (0)
In hospital complications and short- and long-term mortality in patients with type 1 and type 2 myocardial infarction. Data from the SWEDEHEART registry (2013) (0)
Robustness of the troponin 0/1-h algorithm for early diagnosis of acute myocardial infarction when measured on two different instruments of the same type (2019) (0)
P820Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction (2018) (0)
Ischaemia monitoring with on‐line vectorcardiography during dobutamine stress echocardiography in patients after an episode of unstable coronary artery disease (1998) (0)
[Differences in the treatment of patients with type 1 and type 2 myocardial infarction. Guidelines for the treatment of type 2 myocardial infarction are completely missing]. (2015) (0)
In reply. (2016) (0)
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome Coronary Heart Disease (2007) (0)
[Evaluation of patients with chest pain: Can we settle with measurement of troponin only on arrival?]. (2014) (0)
Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial (2022) (0)
2389Survival after myocardial infarction with non-obstructive coronary arteries (MINOCA) - A comprehensive systematic review and meta-analysis (2019) (0)
Signs of failed reperfusion or recurrent ischemia – worse for women (2002) (0)
Effectiveness by gender and age of renin‐angiotensin system blockade in heart failure—A national register‐based cohort study (2020) (0)
[A study in Fagersta: extensive anticoagulant therapy. High incidence of hemorrhagic complications]. (1992) (0)
576 CAD and comorbidities (2015) (0)
P5325A possible paradoxical association between LDL-cholesterol in myocardial infarction patients and relation to major adverse outcomes - a 10-year nationwide cohort study (2019) (0)
Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers (2023) (0)
Poster display I clinical general (2005) (0)
Screening of biomarkers for prediction of multisite artery disease in patients with recent myocardial infarction (2021) (0)
[Unnecessary follow up of myoma. Bleeding disorders are specific symptoms for sarcoma]. (1997) (0)
P5537Biomarkers in addition to clinical characteristics for prediction of peripheral artery disease in patients with recent myocardial infarction (2019) (0)
Abstract 2067: Prognostic Value of Growth-Differentiation Factor-15 in Patients with ST-Elevation Myocardial Infarction (2006) (0)
Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use? (2021) (0)
P4683Combined testing of copeptin and high-sensitivity cardiac troponin T at baseline in comparison to other algorithms for rule-out of acute myocardial infarction (2017) (0)
Do self-reported pregnancy complications add to risk evaluation in older women with established cardiovascular disease? (2019) (0)
[The debate on National Quality Registries: The criticism shows a need of increased knowledge of the purpose of the registries]. (2009) (0)
Abstract 16157: Single Measurement of GDF-15 Provides Reliable Prognostication of Stroke and Major Bleeding in Atrial Fibrillation (2014) (0)
ST-segment resolution – good, but not good enough (2002) (0)
Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain (2018) (0)
Erratum to: Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers. (2021) (0)
THE PROGNOSTIC UTILITY OF A MODIFIED HEART SCORE IN PATIENTS WITH CHEST PAIN IN THE EMERGENCY DEPARTMENT APPLIED TO THE TRAPID-AMI STUDY (2015) (0)
Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden. (2023) (0)
Prognosis of Myocardial Infarction with Non-Obstructive Coronary Arteries – A Systematic Review (2019) (0)
Cardiac troponins for risk assessment a management of non-ST-Elevation (2005) (0)
Cardiac troponin T levels in patients with renal failure (2002) (0)
Temporal changes of biomarkers in myocardial infarction patients with non-obstructive compared to obstructive coronary arteries (2021) (0)
How common is significant coronary artery disease in patients with type 2 myocardial infarction? : Data from the SWEDEHEART registry 2011-2013 (2014) (0)
Lower long term relative survival and higher excess mortality in women and in elderly after acute myocardial infarction: a national cohort study using 180,368 cases from the SWEDEHEART registry (2016) (0)
Beta blocker use and mortality in hospital survivors of acute myocardial infarction without heart failure (2016) (0)
725 Dynamics of the nondipolar components of the T-wave during initial course of thrombolyzed ST-elevation myocardial infarction (2005) (0)
Stress, Social Support and Coronary Disease in Swedish Men and Women : The Sephia Stress Study (2013) (0)
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI) (2022) (0)
Statin treatment intensity, discontinuation and long-term outcome in patients with acute myocardial infarction and impaired kidney function. (2023) (0)
P3641Predicting one year mortality and heart failure with artificial intelligence after a myocardial infarction (2018) (0)
P827Insufficient sensitivity when using undetectable baseline high-sensitivity cardiac troponin T (hs-cTnT <5 ng/L) to rule out myocardial infarction in patients with short time from symptom onset (2018) (0)
The use of neural networks for early diagnosis and exclusion of acute myocardial infarction (1996) (0)
P2723Diagnosis of acute myocardial infarction in the presence of left bundle-branch block (2019) (0)
Incremental value of global longitudinal strain in long-term risk prediction after acute coronary syndrome. A SWEDEHEART registry based echo study (2022) (0)
Outcomes following acute myocardial injury and type 2 myocardial infarction in patients with and without coronary artery disease (2022) (0)
Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized DETO2X-AMI Trial (2022) (0)
Gender differences in the use of invasive strategies and recommended medications for AMI in the EHS 2009 snapshot registry (2013) (0)
Extending treatment effects from a randomized trial using observational data: an application to coronary thrombus aspiration (2021) (0)
[More accurate diagnosis could identify patients suitable for tacrine therapy]. (1996) (0)
Acute coronary syndrome – the present and future role of biomarkers 1 ) (2013) (0)
48 Outcomes following acute myocardial injury and type 2 myocardial infarction in patients with and without coronary artery disease (2022) (0)
Added value of left atrial strain in outcome prediction after myocardial infarction. SWEDEHEART-registry based echocardiographic study (2022) (0)
A novel approach to cardiac troponins to improve the diagnostic work-up in chest pain patients. (2012) (0)
The Relation between Cardiovascular and Periodontal Disease - the PAROKRANK study. (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bertil Lindahl?

Bertil Lindahl is affiliated with the following schools:

Bertil Lindahl's Academic­Influence.com Rankings

Why Is Bertil Lindahl Influential?

Bertil Lindahl's Published Works

Published Works

What Schools Are Affiliated With Bertil Lindahl?

Bertil Lindahl's AcademicInfluence.com Rankings